Icon Clinical Pharmacology — Omaha, Nebraska

Icon Clinical Pharmacology is a clinical research site located in Omaha, Nebraska, United States 68154.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Icon Clinical Pharmacology has participated in 1 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: AstraZeneca.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icon Clinical Pharmacology?

Icon Clinical Pharmacology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icon Clinical Pharmacology conducted?

Icon Clinical Pharmacology has 1 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is Icon Clinical Pharmacology accredited by Crixeo Health?

Icon Clinical Pharmacology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Icon Clinical Pharmacology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.